Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
life sciences
national blog main
boston
boston blog main
boston top stories
clinical trials
deals
fda
investing
san diego blog main
san diego top stories
san francisco blog main
startups
480 biomedical
abide therapeutics
akouos
allergan
amylin pharmaceuticals
arsenal medical
astellas pharmaceuticals
azacitidine
ben cravatt
beta-thalassemia
biotech ipos
bob langer
botox
bristol-myers squibb
california institute for biomedical research
chronic rhinosinusitis
covid-19
dacogen
decibel therapeutics
decitabine
dna
drug delivery
dyne therapeutics
epigenetics
epilepsy
epizyme
What
developing
6
×
therapeutics
6
×
ipo
medicines
company
million
raised
treat
based
biotech
drug
new
public
abide
according
affects
aims
americans
appointed
approach
approved
brings
called
chief
clinical
date
deb
debut
debuted
debuts
diseases
disorders
drugs
dyne
dyne’s
epigenetic
epigenetics
estimated
executive
fda
Language
unset
Current search:
biotech
×
developing
×
therapeutics
×
@techcrunch.com
2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
